[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 531-540

Título :	Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia : Thirty-six-month results from the european schizophrenia outpatient health outcomes study
Tipo de documento:	texto impreso
Autores:	Diego Novick, Autor ; Josep Maria Haro, Autor ; Jordan Bertsch, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 531-540
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Esquizofrenia, TD, EPS, Tratamiento antipsicótico
Resumen:	The incidence of treatment-emergent extrapyramidal symptoms (EPSs) and tardive dyskinesia (TD) in schizophrenic patients, and the clinical characteristics associated with an increased risk of developing EPSs and TD were examined. Patients (N = 7728) in the 3-year, prospective, observational Schizophrenia Outpatient Health Outcomes study were examined according to baseline antipsychotic drug exposure.
Link:	./index.php?lvl=notice_display&id=29426

[artículo] Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia : Thirty-six-month results from the european schizophrenia outpatient health outcomes study [texto impreso] / Diego Novick, Autor ; Josep Maria Haro, Autor ; Jordan Bertsch, Autor . - 2022 . - pp. 531-540.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 531-540

Palabras clave:	Esquizofrenia, TD, EPS, Tratamiento antipsicótico
Resumen:	The incidence of treatment-emergent extrapyramidal symptoms (EPSs) and tardive dyskinesia (TD) in schizophrenic patients, and the clinical characteristics associated with an increased risk of developing EPSs and TD were examined. Patients (N = 7728) in the 3-year, prospective, observational Schizophrenia Outpatient Health Outcomes study were examined according to baseline antipsychotic drug exposure.
Link:	./index.php?lvl=notice_display&id=29426